11ÔÂ28ÈÕ£¬£¬¹ú¼ÒÒ½ÁÆ°ü¹Ü¾ÖÁªºÏÈËÁ¦×ÊÔ´ºÍÉç»á°ü¹Ü²¿ÕýʽÐû²¼ÁË¡¶¹ú¼Ò»ù±¾Ò½ÁÆ°ü¹Ü¡¢¹¤ÉË°ü¹ÜºÍÉúÓý°ü¹ÜҩƷĿ¼(2024Äê)¡·¡£¡£¡£¡£Ôڴ˴θüÐÂÖУ¬£¬È«ÐÂÒ»´ú·Çŵ±´ÌØÀàÒ©Îï--·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒͨ¹ý̸ÅÐÀÖ³ÉÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼£¬£¬Õ⽫Ԥʾן߸ÊÓÍÈýõ¥ÑªÖ¢ÖÎÁÆÊг¡½«Ó­À´ÐµľºÕùת±ä¡£¡£¡£¡£ÏÖÔÚ£¬£¬º£ÄÚÊг¡ÉϽöÓÐÔ­Ñм°ÁªÈðÖÆÒ©Á½¼ÒÆóÒµÉú²úµÄ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¬£¬ÆäÖÐÁªÈðÖÆÒ©Ñб¬·¢²úµÄÊæËÙ´ï®ÊǺ£ÄÚÊ×·ÂÉÏÊеIJúÆ·¡£¡£¡£¡£

Öйú¸ß¸ÊÓÍÈýõ¥ÑªÖ¢£¨HTG£©µÄ»¼²¡Âʸߴï15%£¬£¬HTG ÊǶ¯ÂöÖàÑùÓ²»¯ÐÔÐÄѪ¹Ü¼²²¡£¡£¡£¡£¨ASCVD£©¼°¼±ÐÔÒÈÏÙÑ×µÄΣÏÕÒòËØÖ®Ò»£¬£¬ÇÒÓ볬ÖØ/·ÊÅÖ¡¢2ÐÍÌÇÄò²¡¡¢·Ç¾Æ¾«ÐÔÖ¬·¾ÐԸβ¡¡¢ÂýÐÔÉöÔಡÓÐÃ÷È·¹ØÁª^[1]¡£¡£¡£¡£

½µ¸ÊÓÍÈýõ¥ÓÃÒ©Ö÷Òª°üÀ¨±´ÌØÀà¡¢ω-3Ö¬·¾ËáÀàºÍÑÌËáÀ࣬£¬¾ÝÃ×ÄÚÍøÊý¾ÝÏÔʾ£¬£¬2024ÄêÉÏ°ëÄê½µ¸ÊÓÍÈýõ¥ÓÃÒ©Ò½ÔºÊг¡ÏúÊÛ¹æÄ£µÖ´ï7.4ÒÚ¡£¡£¡£¡£ÓÉÓÚω-3Ö¬·¾ËáÀàÖ÷ҪΪ×ԷѲúÆ·£¬£¬ÑÌËáÀàȱ·¦ïÔÌ­ÐÄѪ¹ÜΣº¦µÄÖ¤¾Ý£¬£¬±´ÌØÀà³ÉΪº£ÄÚÖ÷ÒªÓÃÒ©Ñ¡Ôñ£¬£¬ÆäÖзÇŵ±´ÌØÀàÒ©ÎïÖ¤¾Ý××㣬£¬ÁÙ´²Ó¦ÓÃ×îÆձ飬£¬Õ¼±´ÌØÀàÊг¡µÄ90.31%£¬£¬Í¬±ÈÔöÌí10.39%¡£¡£¡£¡£

·Çŵ±´ÌØ×÷ΪǰÌåÒ©Î£¬ ÐèÒªÔÚ¸ÎÔàÖÐõ¥»¯´úл³É·Çŵ±´ÌØËáºó²Å»ªÊ©Õ¹×÷Ó㬣¬ÓÉÓÚÆäÔÚË®ÖÐÏûÈڶȵͣ¬£¬ÉúÎïʹÓöȲ»¸ß£¬£¬ÇÒÐèÒªËæ²Í·þÓ㬣¬¸ø»¼Õß´øÀ´Î´±ã^[2]¡£¡£¡£¡£±ðµÄ£¬£¬·Çŵ±´ÌØÀàÒ©Îï˵Ã÷ÊéÖеĺڿòÖÒÑÔÒ²ÔöÌíÁËÓëËûÍ¡ÀàÒ©ÎïÁªÓõÄÇå¾²ÐԼǹÒ^[3]¡£¡£¡£¡£Ëæ×Å·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©µÄÉÏÊУ¬£¬ÓÐÓýâ¾öÁËÒÔÉÏÎÊÌâ¡£¡£¡£¡£

·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©ÒÔÆäÓÅ»¯µÄµ¨¼îÑνṹ»ººÍÊͼÁÐÍ£¬£¬ÏÔÖøÌáÉýÁËÉúÎïʹÓöȣ¬£¬Í¬Ê±Æ½»¬ÁËÒ©ÎïŨ¶È·åÖµ£¬£¬ÓÐÓÃÌá¸ßÁË»¼ÕßµÄÒÀ´ÓÐÔ£¬£¬ÇÒÎÞÐè¸ÎÔà´úлÄܹ»Ö±½ÓÔÚÌåÄÚÊ©Õ¹×÷Ó㬣¬´Ó¶ø½µµÍÁ˸ÎÔàµÄ¼ç¸º^[2]¡£¡£¡£¡£

·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©ËµÃ÷ÊéÖÐÃ÷È·Ö¸³ö£¬£¬¿ÉÒÔÓëËûÍ¡ÀàÒ©ÎïÁªºÏʹÓ㬣¬ÇÒÎÞÐèµ÷½â¼ÁÁ¿£¬£¬ïÔÌ­ÁË»¼Õ߶ÔÒ©Îïµ÷½âµÄµ£ÐÄ£¬£¬ÓÐÀûÓÚÌá¸ßÖÎÁƵÄÒÀ´ÓÐԺʹï±êÂÊ£»£»£»ÖðÈÕ½öÐè·þÓÃÒ»´Î£¬£¬Ã¿´ÎÒ»Á££¨135mg£©£¬£¬²»ÊÜÒûʳӰÏ죬£¬ÎÞÐèËæ²Í·þÓÃ^[4]£¬£¬Îª»¼ÕßÌṩÁËÎÞаµÄÓÃÒ©Ñ¡Ôñ£¬£¬½øÒ»²½ÌáÉýÁËÖÎÁƵı㵱ÐÔ¡£¡£¡£¡£

±ðµÄ£¬£¬·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©½ÓÄɵij¦ÈÜ»ºÊÍÊÖÒÕÓÐÖúÓÚƽÎÈÒ©ÎïÔÚÌåÄÚµÄŨ¶Èת±ä£¬£¬ïÔÌ­²»Á¼·´Ó¦£¬£¬Ìá¸ßÁËÓÃÒ©µÄÇå¾²ÐÔ¡£¡£¡£¡£

×÷Ϊ·Çŵ±´ÌصĻîÐÔ´úл²úÆ·£¬£¬·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©ÔÚÁÆЧÎȹÌÐÔ¡¢Çå¾²ÐÔ¡¢±ãµ±ÐԵȷ½ÃæÓÅÊÆÏÔ×Å¡£¡£¡£¡£Ëæ×Å·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ½øÈë¹ú¼ÒÒ½±£Ä¿Â¼£¬£¬½«ÓÐÖúÓÚÁÙ´²ÑªÖ¬ÖÎÀí£¬£¬½µµÍ¸ÊÓÍÈýõ¥£¨TG£©Ë®Æ½£¬£¬ïÔÌ­ÐÄѪ¹ÜÊÂÎñΣº¦£¬£¬Îª¸ß¸ÊÓÍÈýõ¥ÑªÖ¢ÖÎÁÆÊг¡´øÀ´ÐµÄÉú³¤»úÔµ¡£¡£¡£¡£

²úÆ·×ÉѯÈÈÏߣº400 1833 668

²Î¿¼ÎÄÏ×

[1]   ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢ÁÙ´²ÖÎÀí¶àѧ¿Æר¼Ò¹²Ê¶ÊÂÇé×é. ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢¼°ÆäÐÄѪ¹ÜΣº¦ÖÎÀíר¼Ò¹²Ê¶[J].ÖйúÑ­»·ÔÓÖ¾,2023,38(6)£º621-630.

[2]   Elisavet Moutzouri ,Anastazia Kei,Moses S elisaf ,Haralampos J Milionis.Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.Vascular Health and Risk Management 2010:6 525–539.

[3]   ·Çŵ±´ÌؽºÄÒ˵Ã÷Êé.

[4]   ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ˵Ã÷Êé.